Read ’em all here folks: http://onlinelibrary.wiley.com/doi/10.1111/ajt.13164/pdf
Long-Term Living Donor Outcomes: When To Say No Dorry Segev (Pg. 43).
“The risks of donation are real. And serious. And attributable to donating. In other words, there are things that might happen to an individual if he donates that would not happen to that individual had he not donated”
“And of course it will only get worse. No doubt as we follow the new cohort of donors with more medical issues (higher BMI, higher blood pressure, etc.) for much longer periods of time (current follow-up in large studies is relatively still “short-term” or “medium-term”), we will discover much more risk that donors take.”
Note: We/They aren’t following anyone. There is no living donor registry; we don’t even have one-year of comprehensive living donor data.
Non-Academic Transplant Business Intelligence – A Surgeon’s Perspective Robert Osorio (pg 47).
” transplant professional societies now host career development seminars to improve business intelligence among their membership. The paucity of literature is also improving, and reviews are now available regarding the finances of transplantation”
“In 2008, ASTS launched the first comprehensive compensation study for transplant surgeons practicing within the United States4 . These results have provided a better understanding of total compensation, including salary and benefits, of academic staff surgeons, program directors, and academic transplant surgeons in leadership positions. This type of study is readily used in compensation agreements requiring fair market value (FMV) estimates of salary for non-academic transplant surgeons who are in an employed model”
Eliminating the Significant Regional Variation in Donor Conversion Rates Provides the Most Significant Reduction To Waitlist Mortality. (pg 49)
” Redistricting might reduce waitlist mortality and potentially saves 563 lives over 5 years. Here we examine national donor conversion rates and waitlist opportunities.”
Hypertension and Diabetes in Live Kidney Donors and Matched Nondonors (pg 55).
“Living donors had lower diabetes than matched controls immediately after donation, but higher incidence past 10 years. Living donors had substantially higher long-term risk of diabetes. Risk of hypertension increased more quickly over time for black donors than nonblack donors. Hypertension incidence did not differ between donors and controls.”
Patterns of Physician Visits Before and After Living Kidney Donation (pg 66)
“Smokers, donors with less than college education, and male donors (particularly single men) are less likely to visit a PCP annually after-donation, and may benefit from targeted efforts to improve PCP followup.”
Predonation Characteristics Associated With Risk of End-Stage Renal Disease in Live Kidney Donors (pg 70)
“Obese donors and those with a high blood pressure have signifi – cantly higher 15-year risk of ESRD compared with other donors.”
Outcomes After Right Kidney Living Donor Transplant Are Associated With Center Volume (pg 76)
“RKLDT [Right Kidney Living Donor Transplant] is associated with a higher rate of GF [Graft Failure} among centers performing <12 RKLDT annually, whereas there is a 2-fold reduction in the RR of GF among experienced centers ( >12 RKLDT /year).”
Analytic Morphomics Do Not Predict Long-Term Outcomes in Living Kidney Donors (pg 83)
“Survey results were obtained from 598 living kidney donors (response rate 57.6%). The mean follow-up time from donation was 9.1 years. “
” however, 17.0% of patients reported new diagnosis of at least one significant cardiovascular risk factor including: diabetes(2.5%), hypertension(14.0%), kidney disease(1.0%), heart attack(0.3%), and stroke(1.3%).”